In lung cancer, lncRNA-LINP1 can down-regulate transforming growth factor β (TGF- β), a key regulator of EMT in tumor progression, and inhibit tumor EMT through the TGF- β / SMAD pathway [116]. The gene discussed is LINP1; the disease is neoplasm.